Skip to main content
SpringerLink
Log in

Immuuntherapie

  • Nursing challenge
  • Published:
Nursing Aims and scope

Samenvatting

Kanker ontstaat door problemen in het immuunsysteem. Daarom wordt tegen steeds meer kankersoorten immuuntherapie ingezet. In dit artikel aandacht voor checkpoint inhibitors. Met de toets verdien je 2 accreditatiepunten.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuurlijst

  1. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature, 2011 Dec 21; 480: 480-489.

  2. Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest, 2015 Sept 1; 125(9): 3335-3337.

  3. Couzin-Frankel J, Breakthrough of the year 2013. Cancer immunotherapy. Science, 2013 Dec 20: 342: 1432-3.

  4. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010, Aug 19; 363: 711-723.

  5. Hossein Borghaei DO et al. Nivolumab versus Docetaxel in advanced nonsquamous non-small cell lung cancer. N Engl J Med 2015, Oct 22; 373: 1627-1639.

  6. Rijkers GT, Kroese FGM, Kallenberg CGM, et al. Leerboek immunologie. Houten: Bohn Stafleu van Loghum; 2016: 493.

  7. Chen DS, Mellman I. Oncology meets immunology: The Cancer-Immunity Cycle. Cell, 2013 Jul 25; 39: 1-10.

  8. Buchbinder E, Hodi FS. Cytotoxic T-lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest, 2015 Sept 1; 125(9): 3377-3383.

  9. Chen L, Xue H. Anti-PD-1/PD-L1 therapy of human cancer: past, present and future. J Clin Invest, 2015 1; 125(9):3384-3391.

  10. Haanen J, Carbonnel F, Robert C, et al. Management of Toxicities from Immunotherapy: ESMO Clinical Practice Guidelines. Ann Oncol, 2017: 28 (suppl 4); 119–142.

  11. Linardou H, Gogas H. Toxicity management of immunotherapy for patients with metastatic melanoma. Ann Transl Med, 2016 Jul 4: 14; 272.

Download references

Author information

Authors and Affiliations

  1. Verpleegkundig specialist longoncologie, UMC Utrecht, Utrecht, Nederland

    Janneke van der Stap

  2. Longarts, UMC Utrecht, Utrecht, Nederland

    Anne van Lindert

Authors
  1. Janneke van der Stap
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne van Lindert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Stap, J., van Lindert, A. Immuuntherapie. nurs 25, 47–53 (2019). https://doi.org/10.1007/s41193-019-0062-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41193-019-0062-8

Search

Navigation